Skip to main content
. 2022 Jul 8;10(7):1376. doi: 10.3390/microorganisms10071376

Figure 3.

Figure 3

Antibacterial activity of the cell-free extracellular products (CFECP) of L. lactis A12, P. megaterium M4, and Priestia sp. M10 against S. agalactiae (SA) and A. hydrophila (AH). Capital letters indicate significant differences between each probiotic against the control in Streptococcus agalactiae treatment (p < 0.05). Lower-case letters indicate significant differences of each probiotic against the control in Aeromonas hydrophila treatment (p < 0.05). Data represent mean ± SEM (n = 3).